Flushing induced by angiotensin converting enzyme inhibitor therapy. 1989

K R Cohen
Hahnemann University Hospital, Philadelphia, Pennsylvania 19102.

UI MeSH Term Description Entries
D008297 Male Males
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D005483 Flushing A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress. Flushings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K R Cohen
February 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
K R Cohen
January 1991, Therapia Hungarica (English edition),
K R Cohen
February 1990, BMJ (Clinical research ed.),
K R Cohen
April 1990, The Journal of allergy and clinical immunology,
K R Cohen
January 1989, Pharmacotherapy,
K R Cohen
March 1993, Archives of internal medicine,
K R Cohen
January 1999, Clinical cardiology,
K R Cohen
May 2021, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Copied contents to your clipboard!